Real Results Noteworthy Lawyer Search

Community Efforts
Print Page   |   Email Page

Corporate Finance

Print PDF

The business attorneys at Shulman Rogers have extensive experience in a broad array of corporate finance transactions on behalf of companies seeking financing, as well as, publicly traded, private and institutional investors and lenders. 

The companies we represent range in size from start-up companies to significant private and public companies, and their transactions can range in size from under $1 million to well in excess of $300 million.  Many of our attorneys maintain strong relationships with various sources of financing, and also regularly represent many banks, financial institutions and other lenders on debt transactions. This enables us to help our clients achieve their financing objectives. We also handle virtually any type of asset based loan transaction, particularly those involving the financing of government contract receivables.

Examples of our corporate financing experience:

  • Traditional secured and unsecured bank debt
  • Private placements of equity and debt securities
  • Initial Public Offerings and other public offerings of securities
  • Shelf registrations
  • Rule 144A transactions
  • PIPE transactions
  • Reverse merger financings
  • Venture capital financings
  • ESOP transactions
  • Tax exempt bond financings
  • Joint ventures

Representative corporate finance and securities transactions our attorneys have handled include:

  • Private placement of up to $50 million of limited liability company interests on behalf of investment fund to be used to acquire office, multi-family/residential, retail, industrial, land, joint venture, equity, first trust and mezzanine debt and other commercial real estate opportunities in the Mid-Atlantic Region.
  • Private placement of up to $20 million of limited liability company interests on behalf of investment fund to finance purchase of distressed real estate.
  • $10 million PIPE transaction consisting of issuance of convertible debentures and warrants for use in international business acquistions.
  • $7.6 million economic development revenue bond financing on behalf of borrower on bond proceeds to expand manufacturing facilities.
  • Represented local pharmaceutical company in $80 million agreement with major pharmaceutical company to co-market new FDA approved compound.